Hamadani Christine M, Taylor George R, Cecil Amber, Chism Claylee M, Huff Emilia, Dasanayake Gaya, Everett Jaylon, Kaur Amandeep, Monroe George W, Patel Mira, Pierpaoli Elisa, Tanner Eden E L
Department of Chemistry & Biochemistry, The University of Mississippi University MS 38677 USA
Nanoscale Adv. 2025 Jul 11. doi: 10.1039/d5na00233h.
Organ-targeted intravenous (IV) delivery of polymeric nanoparticles (NPs) remains a translational drug delivery challenge, as an overwhelming fraction of the administered dose is typically cleared due to fouling at the nano-bio interface. As a solution, we have developed choline carboxylate ionic liquid (IL)-coated polymeric nanoparticles (IL-NPs) that are able to bypass this mechanism of clearance by exhibiting affinity to red blood cells (RBCs) in whole blood, resulting in significant targeted delivery to the first capillary bed encountered post-IV injection in both mice and rats. Here, we demonstrate that choline carboxylate ionic liquid-coated polymeric nanoparticles exhibit affinity to mouse and human red blood cell membranes in whole blood, and examine the mechanism of action engaged by IL-NPs at the RBC membrane interface. We report the physicochemical impact of varying the anionic alkyl chain structure in choline-based carboxylate ILs, which interfaces on the outermost layer of the NP coating, and reveal that membrane saturation, temperature dependence, and membrane anion transporters all play a role in RBC hitchhiking by IL-NPs.
聚合物纳米颗粒(NPs)的器官靶向静脉内(IV)给药仍然是一个转化药物递送挑战,因为由于纳米-生物界面的污垢,所给药剂量的绝大部分通常会被清除。作为一种解决方案,我们开发了胆碱羧酸盐离子液体(IL)包被的聚合物纳米颗粒(IL-NPs),它们能够通过对全血中的红细胞(RBCs)表现出亲和力来绕过这种清除机制,从而在小鼠和大鼠静脉注射后显著靶向递送至遇到的第一个毛细血管床。在此,我们证明胆碱羧酸盐离子液体包被的聚合物纳米颗粒在全血中对小鼠和人类红细胞膜表现出亲和力,并研究了IL-NPs在RBC膜界面所涉及的作用机制。我们报告了改变基于胆碱的羧酸盐ILs中阴离子烷基链结构的物理化学影响,该结构位于NP包被的最外层界面,并揭示膜饱和度、温度依赖性和膜阴离子转运体在IL-NPs搭便车于RBCs过程中均起作用。